Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation. - Chan KH; Cen P; Shu T; Canfield S; Zhao H; Gonzalez A; Rowe J; Tammisetti V; Ayoub H; Blanco A; Amsbaugh M; Tannir N (The Journal of international medical research, 2026)